99 related articles for article (PubMed ID: 24877563)
21. SIRT2 knockout exacerbates insulin resistance in high fat-fed mice.
Lantier L; Williams AS; Hughey CC; Bracy DP; James FD; Ansari MA; Gius D; Wasserman DH
PLoS One; 2018; 13(12):e0208634. PubMed ID: 30533032
[TBL] [Abstract][Full Text] [Related]
22. Hepatic hexokinase domain containing 1 (HKDC1) improves whole body glucose tolerance and insulin sensitivity in pregnant mice.
Khan MW; Priyadarshini M; Cordoba-Chacon J; Becker TC; Layden BT
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):678-687. PubMed ID: 30543855
[TBL] [Abstract][Full Text] [Related]
23. Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance.
Okada T; Liew CW; Hu J; Hinault C; Michael MD; Krtzfeldt J; Yin C; Holzenberger M; Stoffel M; Kulkarni RN
Proc Natl Acad Sci U S A; 2007 May; 104(21):8977-82. PubMed ID: 17416680
[TBL] [Abstract][Full Text] [Related]
24. PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference.
Shearer AM; Wang Y; Fletcher EK; Rana R; Michael ES; Nguyen N; Abdelmalek MF; Covic L; Kuliopulos A
Hepatology; 2022 Dec; 76(6):1778-1793. PubMed ID: 35603482
[TBL] [Abstract][Full Text] [Related]
25. CD248 promotes insulin resistance by binding to the insulin receptor and dampening its insulin-induced autophosphorylation.
Benedet PO; Safikhan NS; Pereira MJ; Lum BM; Botezelli JD; Kuo CH; Wu HL; Craddock BP; Miller WT; Eriksson JW; Yue JTY; Conway EM
EBioMedicine; 2024 Jan; 99():104906. PubMed ID: 38061240
[TBL] [Abstract][Full Text] [Related]
26. DOCK5 regulates energy balance and hepatic insulin sensitivity by targeting mTORC1 signaling.
Lai Y; Zhao A; Tan M; Yang M; Lin Y; Li S; Song J; Zheng H; Zhu Z; Liu D; Liu C; Li L; Yang G
EMBO Rep; 2020 Feb; 21(2):e49473. PubMed ID: 31885214
[TBL] [Abstract][Full Text] [Related]
27. TNIK is a conserved regulator of glucose and lipid metabolism in obesity.
Pham TCP; Dollet L; Ali MS; Raun SH; Møller LLV; Jafari A; Ditzel N; Andersen NR; Fritzen AM; Gerhart-Hines Z; Kiens B; Suomalainen A; Simpson SJ; Salling Olsen M; Kieser A; Schjerling P; Nieminen AI; Richter EA; Havula E; Sylow L
Sci Adv; 2023 Aug; 9(32):eadf7119. PubMed ID: 37556547
[TBL] [Abstract][Full Text] [Related]
28. The tumor suppressor TMEM127 regulates insulin sensitivity in a tissue-specific manner.
Srikantan S; Deng Y; Cheng ZM; Luo A; Qin Y; Gao Q; Sande-Docor GM; Tao S; Zhang X; Harper N; Shannon CE; Fourcaudot M; Li Z; Kasinath BS; Harrison S; Ahuja S; Reddick RL; Dong LQ; Abdul-Ghani M; Norton L; Aguiar RCT; Dahia PLM
Nat Commun; 2019 Oct; 10(1):4720. PubMed ID: 31624249
[TBL] [Abstract][Full Text] [Related]
29. Impaired insulin signaling in the B10.D2-
Peterson KR; Gutierrez DA; Kikuchi T; Anderson-Baucum EK; Winn NC; Shuey MM; Bolus WR; McGuinness OP; Hasty AH
Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E200-E211. PubMed ID: 31084499
[TBL] [Abstract][Full Text] [Related]
30. Hepatic deletion of p110α and p85α results in insulin resistance despite sustained IRS1-associated phosphatidylinositol kinase activity.
Chaudhari A; Ejeskär K; Wettergren Y; Kahn CR; Rotter Sopasakis V
F1000Res; 2017; 6():1600. PubMed ID: 29983910
[No Abstract] [Full Text] [Related]
31. Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease.
Samuel VT; Liu ZX; Wang A; Beddow SA; Geisler JG; Kahn M; Zhang XM; Monia BP; Bhanot S; Shulman GI
J Clin Invest; 2007 Mar; 117(3):739-45. PubMed ID: 17318260
[TBL] [Abstract][Full Text] [Related]
32. Heterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat diet.
Beiroa D; Romero-Picó A; Langa C; Bernabeu C; López M; López-Novoa JM; Nogueiras R; Diéguez C
PLoS One; 2013; 8(1):e54591. PubMed ID: 23336009
[TBL] [Abstract][Full Text] [Related]
33. Epidermal Growth Factor Receptor in Hepatic Endothelial Cells Suppresses MCP-1-Dependent Monocyte Recruitment in Diabetes.
Zhang X; Ohayon-Steckel L; Coppin E; Johny E; Dasari A; Florentin J; Vasamsetti S; Dutta P
J Immunol; 2023 May; 210(9):1363-1371. PubMed ID: 36946774
[TBL] [Abstract][Full Text] [Related]
34. Unraveling the mysteries of hepatic insulin signaling: deconvoluting the nuclear targets of insulin.
Kitamoto T; Accili D
Endocr J; 2023 Sep; 70(9):851-866. PubMed ID: 37245960
[TBL] [Abstract][Full Text] [Related]
35. Tannic Acid Ameliorates Systemic Glucose and Lipid Metabolic Impairment Induced by Low-Dose T-2 Toxin Exposure.
Wang J; Qu J; Liu S; Xu Q; Li X; Zhu Y; Liu X; Yi J; Yuan Z; Huang P; Yin Y; Wen L; Wu J
J Agric Food Chem; 2023 Aug; 71(33):12574-12586. PubMed ID: 37525894
[TBL] [Abstract][Full Text] [Related]
36. FoxO1 as a tissue-specific therapeutic target for type 2 diabetes.
Teaney NA; Cyr NE
Front Endocrinol (Lausanne); 2023; 14():1286838. PubMed ID: 37941908
[TBL] [Abstract][Full Text] [Related]
37. Transgenic rescue of insulin receptor-deficient mice.
Okamoto H; Nakae J; Kitamura T; Park BC; Dragatsis I; Accili D
J Clin Invest; 2004 Jul; 114(2):214-23. PubMed ID: 15254588
[TBL] [Abstract][Full Text] [Related]
38. MAD2-Dependent Insulin Receptor Endocytosis Regulates Metabolic Homeostasis.
Park J; Hall C; Hubbard B; LaMoia T; Gaspar R; Nasiri A; Li F; Zhang H; Kim J; Haeusler RA; Accili D; Shulman GI; Yu H; Choi E
Diabetes; 2023 Dec; 72(12):1781-1794. PubMed ID: 37725942
[TBL] [Abstract][Full Text] [Related]
39. Proximity to Delivery Alters Insulin Sensitivity and Glucose Metabolism in Pregnant Mice.
Musial B; Fernandez-Twinn DS; Vaughan OR; Ozanne SE; Voshol P; Sferruzzi-Perri AN; Fowden AL
Diabetes; 2016 Apr; 65(4):851-60. PubMed ID: 26740602
[TBL] [Abstract][Full Text] [Related]
40. Cmah deficiency blunts cellular senescence in adipose tissues and improves whole-body glucose metabolism in aged mice.
Takeda R; Tabuchi A; Nonaka Y; Kano R; Sudo M; Kano Y; Hoshino D
Geriatr Gerontol Int; 2023 Dec; 23(12):958-964. PubMed ID: 37968438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
